scorecardresearch
Thursday, August 7, 2025
TopicFDA

Topic: FDA

US rejection of emergency use for Covaxin will not impact India’s vaccination drive: Govt

NITI Aayog member V K Paul said that he respected US' decision and hoped that the vaccine manufacturer will comply with the parameters of their regulatory system.

US FDA approves first new Alzheimer’s drug in 20 years despite warnings from experts

The new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, but only slowed it in one study. The drug is given as an infusion every four weeks.

US FDA authorises Johnson & Johnson single dose vaccine

President Joe Biden described the approval as an encouraging development in efforts to end the Covid-19 crisis and said this is exciting news for all US citizens.

US pet food company recalls products after 70 dogs die due to suspected poisoning

US FDA noted that all cat and dog products from Midwestern Pet Foods may contain high levels of aflatoxin that could have been behind the deaths.

Pfizer to seek emergency US FDA authorisation for its Covid vaccine today

Shown to be 95% effective, Pfizer's vaccine could be the first to be cleared for use, but before that, it must clear the FDA's thorough vetting process, which could take at least 3 weeks.

Antibiotic Teicoplanin 10 times more effective than Covid drugs like HCQ, says IIT Delhi study

Teicoplanin is an FDA-approved glycopeptide antibiotic, which is regularly used for treating Gram-positive bacterial infections with low toxicity profile in humans.

Covid vaccine to be widely available in the US by April, CDC chief says

About 700 million vaccine doses should be available by April. The vaccine candidates that are furthest along in development will need a two-dose regimen, CDC chief Redfield said.

US FDA is setting a higher bar for emergency Covid vaccine approvals

FDA says it will need more robust data about how well a Covid vaccine works before granting an emergency waiver, building on guidelines that say it should be at least 50% effective.

Why big pharma needs to do more to counter Covid vaccine politics

9 Covid vaccine developers signed a pledge saying they won't submit their inoculations for Food & Drug Administration approval until they show safety & efficacy in late-stage trial.

Convalescent plasma therapy holds promise, but here’s why scientists are still studying it

US approves emergency use of convalescent plasma to treat Covid-19, but studies conducted so far don't hold enough evidence to prove it works effectively and without risk. 

On Camera

AI integration for military is risky business. Combat monopoly must remain with soldiers

The Army has plans for a technology thrust in the near term, including the use of AI to support decision-making. While well-intentioned, this may have unintended consequences.

Web of spoof sites, scam call centres. Crypto theft racket modus operandi in focus amid ED crackdown

As part of the crypto theft racket, businessman Chirag Tomar and his aides targeted 542 victims and managed to steal a total of Rs 19.9 million.

Pakistan army chief Asim Munir to attend CENTCOM chief’s farewell, second visit to US in two months

Munir was earlier in America in June when he had a two-hour luncheon meeting with the US president at the White House.

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.